<DOC>
	<DOCNO>NCT01482624</DOCNO>
	<brief_summary>The primary objective clinical investigation determine whether post-arthroscopic treatment 10 ml 0.5 % sodium hyaluronate ( VISCOSEAL® SYRINGE ) relief pain , improve mobility promote joint recovery , compare standard arthroscopy procedure alone , patient undergo arthroscopic procedure .</brief_summary>
	<brief_title>Intra-articular Hyaluronan After Arthroscopic Meniscal Surgery</brief_title>
	<detailed_description />
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>Male female patient 18 75 year age . Good general health condition . Signed write informed consent . Patients necessity arthroscopic meniscal surgery . Ensured compliance subject whole study period . Concomitant previous participation clinical investigation within last 3 month prior study inclusion . Knee joint arthroscopy study relevant joint within 6 month prior study inclusion . Patients know hypersensitivity investigational device ( i.e . active compound excipients ) component procedure use study . Contraindication use investigational product schedule arthroscopy , use anesthesia postsurgical treatment . Concomitant disease sufficient severity ( e.g . uncontrolled diabetes mellitus , carcinoma , etc . ) , opinion investigator , may put patient risk participate study , affect patient 's ability take part study . Concomitant disease sufficient severity study relevant joint ( e.g . know suspected infection , peripheral neuropathy presence hemarthros ) . List concomitant medication allow interfere functional assessment study . Use medication contraindicate arthroscopic surgery . Intraarticular treatment sodium hyaluronatebased product within last 6 month use corticosteroid contain substance within last 3 month study relevant joint . Recent history drug and/or alcohol abuse ( within last 6 month ) patient severe mental illness suicidal tendency . Pregnant lactating female . Participants childbearing age ( premenopausal ) accept use method birth control pearl index ≤ 1 % ( i.e . oral contraceptive , vaginal ring , hormonereleasing Intrauterine Device ( IUD ) , implant , depot syrinx , hormone patch , double barrier method , tubal ligation , vasectomise partner , … ) treatment period first 4 week followup period . Subjects high probability noncompliance study procedure accord investigator 's judgement ( like illiteracy , insufficient knowledge local language ) . Kellgren IIIIV study relevant side ( confirmed Xray ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>hyaluronan</keyword>
	<keyword>hyaluronic acid</keyword>
</DOC>